International Conference and Exhibition on Biowaivers and Biosimilars, USA

Biosimilars have provided many challenges and opportunities in equal measure for innovators and applicants. Biosimilars-2012 is designed to discuss the development and progress of research in the areas of drug discovery, clinical trials, regulatory and economic considerations towards Biosimilars and Biowaivers.

Important Dates:
Avail the early bird discounts and register on/before April 02, 2012.
Abstract Submission closes on: July 20, 2012
Registration closes on: July 29, 2012
On spot Registration: September 10, 2012

We warmly invite you to attend and submit your abstract to World Congress and Expo on Biowaivers and Biosimilars.

Biosimilars-2012 is comprised of 11 tracks and 58 sessions designed to offer comprehensive sessions that address current issues related to Biowaivers and Biosimilars.

Who should attend?
Legal affairs, principal scientists, chief scientific officers, regulatory affairs, Healthcare agencies, Pharmacovigilance, Directors, Deans, Professors and Associate Professors from universities, CEOs and Managers from follow-on-Biologic, Health economics, Bio-pharmaceuticals, Drug safety and risk management, Research and Development and commercial affairs, Ph.D scholars and researchers.

Further details and to register